Evidence map›Paper›PMID 22812662›Full record

ArticleBiochemistry2012

In vitro formation and characterization of the skeletal muscle α·β tropomyosin heterodimers.

Athanasia Kalyva, Anja Schmidtmann, Michael A Geeves

Abstract read
In one paragraph

Article in Biochemistry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Review
  2. Article
  3. A Novel Variant inInternational journal of molecular sciences · 2023
    Article
  4. Structural and Functional Properties of Kappa Tropomyosin.International journal of molecular sciences · 2023
    Article
  5. Article
  6. Mutations Q93H and E97K inInternational journal of molecular sciences · 2021
    Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Polymorphism in tropomyosin structure and function.Journal of muscle research and cell motility · 2013
    Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Athanasia KalyvaSchool of Biosciences, University of Kent, Canterbury, CT2 7NJ, UK.
Anja Schmidtmann
Michael A Geeves

Funding

British Heart FoundationWellcome Trust 085309
6 · The paper itself

Abstract

Tropomyosin (Tm) is a dimer made of two alpha helical chains associated into a parallel coiled-coil. In mammalian skeletal and cardiac muscle, the Tm is expressed from two separate genes to give the α- and β-Tm isoforms. These associate in vivo to form homo- (α(2)) and heterodimers (α·β) with little β(2) normally observed. The proportion of α(2) vs α·β varies across species and across muscle types from almost 100% α(2)- to 50% α·β-Tm. The ratio can also vary during development and in disease. The functional significance of the presence of these two isoforms has not been defined because it is difficult to isolate or purify the α·β dimer for functional studies. Here we report an effective method for purifying bacterially expressed Tm as α·β dimers using a cleavable N-terminal tag on one of the two chains. The same method can be used to isolate Tm dimers in which one chain carries a mutation. We go on to show that the α·β dimers differ in key properties (actin affinity, thermal stability) from either the α(2)- or β(2)-Tm. However, the ability to regulate myosin binding when combined with cardiac troponin appears unaffected.

Indexed as

ActinsAnimalsCalciumCircular DichroismHot TemperatureMuscle, SkeletalProtein BindingProtein MultimerizationProtein StabilityProtein UnfoldingRabbitsRatsRecombinant ProteinsTropomyosinActinsCalciumRecombinant ProteinsTropomyosin

Identifiers

PMID22812662
PMCPMC3535570

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.